BioWorld MedTech
Archive Search

User ID

Password

Forgot password

Remember my login



New User ?

BioWorld MedTech Twitter

Clarivate Analytics

Today's Issue of BioWorld MedTech

Saturday, December 16, 2017

Today's Headlines

Insightec garners $150M series E funding round for MR-guided focused ultrasound technology

Insightec Ltd. has closed a $150 million series E financing, led by Koch Disruptive Technologies, a Koch Industries subsidiary. Funding will be used to commercialize its MRI-guided focused ultrasound (MRgFUS) device as well as expand research into further indications.

Livanova to divest CRM business to Microport for about $190M in cash

Livanova plc has agreed to sell its cardiac rhythm management division to medical device manufacturer, Microport Scientific Corp., for $190 million in cash. Livanova will turn its focus to its remaining divisions in cardiac surgery and neuromodulation.

Stryker $215M Vexim buy will rebalance spine market

PARIS – A major new deal has been concluded in the world of med-techs. Stryker Corp. of Kalamazoo, Mich., has just made a tender offer for Balma, France-based Vexim SA. The U.S. orthopedics giant paid $215.7 million to acquire this French company specializing in minimally invasive treatment of vertebral fractures, which has been listed on the Euronext Growth market since 2012. "This integration will help us speed up international development of our technology for repairing vertebral fractures and consolidate our position in Europe," Vincent Gardès, CEO of Vexim, told BioWorld MedTech.


Home   |   About Us   |   Contact Us   |   Copyright Notices   |   Terms of Use   |   Privacy Statement

clarivate.com | BioWorld.com | bioworldmedtech.com